Stock NUS NU SKIN ENTERPRISES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Nu Skin Enterprises, Inc.

Equities

NUS

US67018T1051

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-26 pm EDT 		5-day change 1st Jan Change
12.31 USD +0.57% Intraday chart for Nu Skin Enterprises, Inc. -5.38% -36.61%
Mar. 18 Nu Skin Enterprises, Inc. Announces Retirement of Andrew Lipman as Board of Directors CI
Feb. 15 Sector Update: Consumer Stocks Advance Premarket Thursday MT

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • With a P/E ratio at 12.37 for the current year and 8.29 for next year, earnings multiples are highly attractive compared with competitors.
  • The company shows low valuation levels, with an enterprise value at 0.45 times its sales.
  • Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company sustains low margins.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Personal Products

1st Jan change Capi. Investor Rating ESG Refinitiv
NU SKIN ENTERPRISES, INC. Stock Nu Skin Enterprises, Inc.
-36.61% 611M
C+
PROCTER & GAMBLE COMPANY Stock Procter & Gamble Company
+10.07% 381B
C-
COLGATE-PALMOLIVE COMPANY Stock Colgate-Palmolive Company
+14.18% 74.67B
A+
HINDUSTAN UNILEVER LIMITED Stock Hindustan Unilever Limited
-16.59% 62.59B
A-
ESTEE LAUDER Stock Estee Lauder
+0.82% 52.86B
B+
KENVUE INC. Stock Kenvue Inc.
-12.40% 36.11B -
BEIERSDORF Stock Beiersdorf
+3.54% 33.57B
B-
ESSITY AB Stock Essity AB
+7.92% 17.29B
A-
GODREJ CONSUMER PRODUCTS LIMITED Stock Godrej Consumer Products Limited
+6.30% 14.75B
B
DABUR INDIA LIMITED Stock Dabur India Limited
-8.65% 10.82B
C+
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. NUS Stock
  4. Ratings Nu Skin Enterprises, Inc.